Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Routine pediatric and adult vaccine antigens represent a broad category of biological substances used to induce acquired immunity against specific infectious diseases. These antigens include a variety of molecular forms, such as inactivated or attenuated pathogens, purified subunits, toxoids, and nucleic acids (mRNA) that encode viral proteins (CDC, 2024). In pediatric populations, routine antigens target childhood illnesses like measles, mumps, rubella, and polio, while adult schedules emphasize protection against influenza, shingles, and pneumococcal disease. The primary biological role of these antigens is to serve as decoys that train the immune system to recognize and neutralize specific bacteria or viruses. By establishing immunological memory, these antigens prevent the onset of disease or significantly reduce its severity upon subsequent exposure to the wild-type pathogen (WHO, 2023). While generally safe, the administration of these antigens can lead to transient side effects like local inflammation or fever, reflecting the activation of the innate immune response.
Vaccine antigens function by mimicking the molecular structure of pathogens to stimulate the host's immune system without causing disease. They are processed by antigen-presenting cells (APCs) and presented via Major Histocompatibility Complex (MHC) molecules to T-cells. This triggers a cascade involving B-cell activation, antibody production, and the generation of long-lived memory B and T cells, providing protection against future infections by the actual pathogen (Pollard & Bijker, 2021; StatPearls, 2023).
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Routine pediatric and adult vaccine antigens.